Figure 6.
Overall survival in USC inoculated mice after treatment with weekly rituximab, T or T-DM1. Significantly prolonged overall survival is seen in the T-DM1-treated group compared to the other two treatment groups (P = 0.0001).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.